退行性腰椎管狭窄症：NASS循证医学指南解读

2020-08-05 天津中医药大学学报.2020.39(4):398-403.

退行性腰椎管狭窄症（DLSS）是临床上常见的腰椎退行性疾病，为提供最佳、有效的诊断及治疗方案，2011年北美脊柱外科协会更新了DLSS 循证临床实践指南。在充分研读最新版NASS 指南的基础上，结合目

中文标题：

发布机构：

发布日期：

2020-08-05

简要介绍：

退行性腰椎管狭窄症（DLSS）是临床上常见的腰椎退行性疾病，为提供最佳、有效的诊断及治疗方案，2011年北美脊柱外科协会更新了DLSS 循证临床实践指南。在充分研读最新版NASS 指南的基础上，结合目前最新研究进展，对DLSS 的临床诊治展开评述，并提出未来研究建议。

相关资料下载：

GetToolGuiderByIdResponse(projectId=1, id=1e5e71c0019e2096, title=退行性腰椎管狭窄症：NASS循证医学指南解读, enTitle=, guiderFrom=天津中医药大学学报.2020.39(4):398-403., authorId=0, author=, summary=退行性腰椎管狭窄症（DLSS）是临床上常见的腰椎退行性疾病，为提供最佳、有效的诊断及治疗方案，2011年北美脊柱外科协会更新了DLSS 循证临床实践指南。在充分研读最新版NASS 指南的基础上，结合目, cover=https://img.medsci.cn/2020916/1600186460529_2020535.jpg, journalId=0, articlesId=null, associationId=0, associationName=, associationIntro=, copyright=0, guiderPublishedTime=Wed Aug 05 00:00:00 CST 2020, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #333333;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>退行性腰椎管狭窄症（DLSS）是临床上常见的腰椎退行性疾病，为提供最佳、有效的诊断及治疗方案，2011年北美脊柱外科协会更新了DLSS 循证临床实践指南。在充分研读最新版NASS 指南的基础上，结合目前最新研究进展，对DLSS 的临床诊治展开评述，并提出未来研究建议。</p> </div> </div> </div>, tagList=[TagDto(tagId=6326, tagName=腰椎管狭窄症)], categoryList=[CategoryDto(categoryId=10, categoryName=骨科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=6326, guiderKeyword=腰椎管狭窄症, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=解读, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=3318, appHits=267, showAppHits=0, pcHits=965, showPcHits=3051, likes=0, shares=18, comments=11, approvalStatus=1, publishedTime=Wed Sep 16 00:16:05 CST 2020, publishedTimeString=2020-08-05, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Wed Sep 16 00:14:33 CST 2020, updatedBy=2020535, updatedName=qiushida2, updatedTime=Sat Jan 06 04:14:58 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=退行性腰椎管狭窄症_NASS循证医学指南解读_王宝剑.pdf)])

退行性腰椎管狭窄症_NASS循证医学指南解读_王宝剑.pdf

下载请点击：

评论区 (9)

#插入话题

插入图片

[GetPortalCommentsPageByObjectIdResponse(id=1188329, encodeId=c612118832973, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c0d55448558, createdName=牟文文, createdTime=Wed Jan 26 16:36:28 CST 2022, time=2022-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1078367, encodeId=43df10e83674a, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/hZGpKXAvteWbg1PaXwxCy7vNghCiclSUoQe6hQhyyEnW3YHJJodDiaIib7zCDdoNNbicN5Dd5H0zgq4guJopgbhhhg/132, createdBy=c7f95272180, createdName=l00710071, createdTime=Thu Dec 09 10:02:56 CST 2021, time=2021-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076250, encodeId=c36510e62508c, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e8b55317987, createdName=148a0d05m78暂无昵称, createdTime=Thu Dec 02 16:18:11 CST 2021, time=2021-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004228, encodeId=01451004228aa, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210731/a4b1413518fb47b19954324101cd1983/d803e94ba7ae40a49239c675765296d6.jpg, createdBy=af9e5538367, createdName=shiyizowie, createdTime=Sat Jul 31 13:45:46 CST 2021, time=2021-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1002864, encodeId=ae51100286418, content=不想被忽悠, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7425491601, createdName=ms6000000119777328, createdTime=Mon Jul 26 22:36:13 CST 2021, time=2021-07-26, status=1, ipAttribution=)]
2022-01-26 牟文文

谢谢

47 0
[GetPortalCommentsPageByObjectIdResponse(id=1188329, encodeId=c612118832973, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c0d55448558, createdName=牟文文, createdTime=Wed Jan 26 16:36:28 CST 2022, time=2022-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1078367, encodeId=43df10e83674a, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/hZGpKXAvteWbg1PaXwxCy7vNghCiclSUoQe6hQhyyEnW3YHJJodDiaIib7zCDdoNNbicN5Dd5H0zgq4guJopgbhhhg/132, createdBy=c7f95272180, createdName=l00710071, createdTime=Thu Dec 09 10:02:56 CST 2021, time=2021-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076250, encodeId=c36510e62508c, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e8b55317987, createdName=148a0d05m78暂无昵称, createdTime=Thu Dec 02 16:18:11 CST 2021, time=2021-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004228, encodeId=01451004228aa, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210731/a4b1413518fb47b19954324101cd1983/d803e94ba7ae40a49239c675765296d6.jpg, createdBy=af9e5538367, createdName=shiyizowie, createdTime=Sat Jul 31 13:45:46 CST 2021, time=2021-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1002864, encodeId=ae51100286418, content=不想被忽悠, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7425491601, createdName=ms6000000119777328, createdTime=Mon Jul 26 22:36:13 CST 2021, time=2021-07-26, status=1, ipAttribution=)]
2021-12-09 l00710071

谢谢

60 0
[GetPortalCommentsPageByObjectIdResponse(id=1188329, encodeId=c612118832973, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c0d55448558, createdName=牟文文, createdTime=Wed Jan 26 16:36:28 CST 2022, time=2022-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1078367, encodeId=43df10e83674a, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/hZGpKXAvteWbg1PaXwxCy7vNghCiclSUoQe6hQhyyEnW3YHJJodDiaIib7zCDdoNNbicN5Dd5H0zgq4guJopgbhhhg/132, createdBy=c7f95272180, createdName=l00710071, createdTime=Thu Dec 09 10:02:56 CST 2021, time=2021-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076250, encodeId=c36510e62508c, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e8b55317987, createdName=148a0d05m78暂无昵称, createdTime=Thu Dec 02 16:18:11 CST 2021, time=2021-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004228, encodeId=01451004228aa, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210731/a4b1413518fb47b19954324101cd1983/d803e94ba7ae40a49239c675765296d6.jpg, createdBy=af9e5538367, createdName=shiyizowie, createdTime=Sat Jul 31 13:45:46 CST 2021, time=2021-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1002864, encodeId=ae51100286418, content=不想被忽悠, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7425491601, createdName=ms6000000119777328, createdTime=Mon Jul 26 22:36:13 CST 2021, time=2021-07-26, status=1, ipAttribution=)]
2021-12-02 148a0d05m78暂无昵称

学习了

54 0
[GetPortalCommentsPageByObjectIdResponse(id=1188329, encodeId=c612118832973, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c0d55448558, createdName=牟文文, createdTime=Wed Jan 26 16:36:28 CST 2022, time=2022-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1078367, encodeId=43df10e83674a, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/hZGpKXAvteWbg1PaXwxCy7vNghCiclSUoQe6hQhyyEnW3YHJJodDiaIib7zCDdoNNbicN5Dd5H0zgq4guJopgbhhhg/132, createdBy=c7f95272180, createdName=l00710071, createdTime=Thu Dec 09 10:02:56 CST 2021, time=2021-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076250, encodeId=c36510e62508c, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e8b55317987, createdName=148a0d05m78暂无昵称, createdTime=Thu Dec 02 16:18:11 CST 2021, time=2021-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004228, encodeId=01451004228aa, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210731/a4b1413518fb47b19954324101cd1983/d803e94ba7ae40a49239c675765296d6.jpg, createdBy=af9e5538367, createdName=shiyizowie, createdTime=Sat Jul 31 13:45:46 CST 2021, time=2021-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1002864, encodeId=ae51100286418, content=不想被忽悠, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7425491601, createdName=ms6000000119777328, createdTime=Mon Jul 26 22:36:13 CST 2021, time=2021-07-26, status=1, ipAttribution=)]
2021-07-31 shiyizowie

学习了

62 0
[GetPortalCommentsPageByObjectIdResponse(id=1188329, encodeId=c612118832973, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c0d55448558, createdName=牟文文, createdTime=Wed Jan 26 16:36:28 CST 2022, time=2022-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1078367, encodeId=43df10e83674a, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/hZGpKXAvteWbg1PaXwxCy7vNghCiclSUoQe6hQhyyEnW3YHJJodDiaIib7zCDdoNNbicN5Dd5H0zgq4guJopgbhhhg/132, createdBy=c7f95272180, createdName=l00710071, createdTime=Thu Dec 09 10:02:56 CST 2021, time=2021-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076250, encodeId=c36510e62508c, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e8b55317987, createdName=148a0d05m78暂无昵称, createdTime=Thu Dec 02 16:18:11 CST 2021, time=2021-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004228, encodeId=01451004228aa, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210731/a4b1413518fb47b19954324101cd1983/d803e94ba7ae40a49239c675765296d6.jpg, createdBy=af9e5538367, createdName=shiyizowie, createdTime=Sat Jul 31 13:45:46 CST 2021, time=2021-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1002864, encodeId=ae51100286418, content=不想被忽悠, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7425491601, createdName=ms6000000119777328, createdTime=Mon Jul 26 22:36:13 CST 2021, time=2021-07-26, status=1, ipAttribution=)]
2021-07-26 ms6000000119777328

不想被忽悠

68 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

骨科指南

退行性腰椎管狭窄症：NASS循证医学指南解读

相关指南

拓展阅读

科室

工具

服务